What CAH’s Earnings Track Record Actually Says
Cardinal Health has compiled a perfect reported beat streak over the last eight quarters, hitting or exceeding the official consensus in all eight prints and posting an average earnings surprise of 10.8%. On the surface, that consistency suggests the company has routinely cleared the bar Wall Street sets. Yet the post-earnings price action tells a different story: across those same eight quarters, the average 5-day return in the trading days after the report is -0.78%, classified as a down drift.
The disconnect is visible in the most recent releases. For the quarter reported on April 30, 2026, CAH delivered EPS of $3.17 against a $2.79 estimate, a 13.6% beat. The stock rose 1.22% the next session but then fell 3.94% over the next five days. The February 5, 2026 print was similar: EPS came in at $2.63 versus $2.34, a 12.4% surprise, yet the stock slipped 0.38% the next day and dropped 5.33% over the following week. The October 30, 2025 quarter is the one exception in this four-quarter window, with a $2.55 actual versus a $2.18 estimate (17% surprise) and a 5-day gain of 4.29%. So while the headline numbers have been strong, a beat has not reliably produced a sustained rally in the days that follow.
Options-Flow Dynamics Around the August 11 Print
CAH’s next scheduled earnings release is August 11, 2026, before the market opens, with the official consensus EPS estimate at $2.42. Because bets on healthcare distributors frequently price in a directional move around events, options flow ahead of the report can create its own mechanics. If short-dated call or put open interest is concentrated around the nearest expiration, dealers may need to hedge through the stock, which can both amplify intraday volatility and create a “pin” effect once the binary event passes.
After the announcement, implied volatility typically compresses, meaning the options market is pricing less future movement than it did before the print. If CAH’s realized post-earnings move turns out to be smaller than what the straddle implied, long options positions can lose premium even if the stock moves in the right direction. Given the historical pattern of beats followed by a down 5-day drift, a post-event unwind is a plausible scenario to monitor, especially if positioning had become one-sided into the release.
What a Disciplined Trader Watches
A disciplined approach to CAH around earnings starts with comparing the actual result to the $2.42 consensus and to the 10.8% average surprise. A smaller beat may be interpreted differently than a double-digit blowout, and the last four quarters show that the size of the beat does not directly determine the five-day direction. Equally important is watching how the stock behaves in the first session after the report and whether any opening gap gets faded or extended over the following week.
Technical context also matters. CAH closed at $230.03, with the 50-day exponential moving average at $223.48 and the RSI at 53.3, a neutral reading. Whether the post-earnings reaction holds above or breaks below the 50-day EMA can help frame the strength of the move. Sector flows in Healthcare/Medical Distribution can add another layer, since group rotation can override company-specific news. Finally, tracking options flow, implied volatility, and any unusual volume spikes in the first 24 hours after the report can reveal whether the market’s real expectation was already priced in.
Frequently Asked Questions
What is Cardinal Health’s beat rate over the last eight reported quarters?
CAH has beaten earnings estimates in all eight of the last reported quarters, for a 100% beat rate, with an average earnings surprise of 10.8%.
What has CAH’s average 5-day post-earnings move been?
Across the last eight reported quarters, the average 5-day price move after earnings is -0.78%, classified as a down drift.
How did CAH trade after its most recent earnings report?
On April 30, 2026, CAH reported EPS of $3.17 versus a $2.79 estimate, a 13.6% beat. The stock rose 1.22% the next day but fell 3.94% over the following five trading days.
For a deeper dive into institutional positioning, analyst estimate revisions, and how sell-side models are modeling the next quarter, readers should explore the full institutional verdict on the ticker page.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-04-30 | $3.17 | $2.79 | +13.6% | +1.22% | -3.94% |
| 2026-02-05 | $2.63 | $2.34 | +12.4% | -0.38% | -5.33% |
| 2025-10-30 | $2.55 | $2.18 | +17% | +0.49% | +4.29% |
| 2025-08-12 | $2.08 | $2.04 | +2% | +1.24% | +1.86% |
| 2025-05-01 | $2.35 | $2.17 | +8.3% | - | - |
| 2025-01-30 | $1.93 | $1.74 | +10.9% | - | - |
Previous CAH editions
Get the institutional verdict on CAH
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the CAH verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.